Citation Impact
Citing Papers
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers
2000
Engineering precision nanoparticles for drug delivery
2020 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems
2000
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Comparing antibody and small-molecule therapies for cancer
2006
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs
2007
Microemulsion-based media as novel drug delivery systems
2000 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Evolution and clinical translation of drug delivery nanomaterials
2017
Animal models for the study of intestinal lymphatic drug transport
2001
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
1999
Pharmacology and therapeutic potential of interferons
2012
Stimuli-responsive supramolecular polymeric materials
2012 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Paving the Road for RNA Therapeutics
2020
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998 Standout
In vitro assessment of oral lipid based formulations
2001
FcRn mediates elongated serum half-life of human IgG in cattle
2006
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
2002
Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin in Patients with Early-Onset Ventilator-Associated Pneumonia
2003
Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration
1996
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Light controlled protein release from a supramolecular hydrogel
2010
Fluoroquinolones: Action and Resistance
2003
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine
2004
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
2014
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
2020
Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
2008
The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids
2005
Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids
2000
Myocarditis
2000 Standout
Treatment of picornavirus infections
2002
Quantitative measurement of cytosolic penetration using the chloroalkane penetration assay
2020
‘Stealth’ lipid-based formulations: Poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug
2014
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs
2003
Clinical targeting of the TNF and TNFR superfamilies
2013
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
2004
Pharmacological significance of glycosylation in therapeutic proteins
2009
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
Pegylation
2001
A Clinical Single-Pass Perfusion Investigation of the Dynamic in Vivo Secretory Response to a Dietary Meal in Human Proximal Small Intestine
2006
FcRn: the neonatal Fc receptor comes of age
2007 Standout
Infective endocarditis
2004 Standout
In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa
2003
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
2004
The effect of protein structure on their controlled release from an injectable peptide hydrogel
2010
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
2020
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
CD40-CD40 ligand
2000
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
1997
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Antiviral Treatment With WIN 54 954 Reduces Mortality in Murine Coxsackievirus B3 Myocarditis
1996
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Functional π-Gelators and Their Applications
2014 Standout
Atacicept: targeting B cells in multiple sclerosis
2010
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration
1998
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
2004 Standout
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Setting and Revising Antibacterial Susceptibility Breakpoints
2007
Works of Mark Rogge being referenced
Targeting RNA : A Transformative Therapeutic Strategy
2019
Comparative Pharmacokinetics and Pharmacodynamics of Two Recomhinant Human Interferon Beta-la (IFNβ-la) Products Administered Intramuscularly in Healthy Male and Female Volunteers
1997
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
2007
Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound
1992
Absorption of Danazol After Administration to Different Sites of the Gastrointestinal Tract and the Relationship to Single‐ and Double‐Peak Phenomena in the Plasma Profiles
1993
A Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and Biology
2011
Protein therapeutics: new applications for pharmacogenetics
2006
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
1993
Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.
1995
Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects
1997
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug
1989
Pharmacokinetics and Pharmacodynamics of Interferon Beta-1a (IFN??-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration
1997
Pharmacokinetics/Dynamics of 5c8, a Monoclonal Antibody to CD154 (CD40 Ligand) Suppression of an Immune Response in Monkeys
1998
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
1997
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses
1992